Seroatlas · Human Serome Atlas

ASL

Argininosuccinate lyase

Also known as: ARLY_HUMAN, ASAL

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P04424
Gene
ASL
Ensembl
ENSG00000126522
Chromosome
7
Canonical length
464 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

464 residues, UniProt reviewed canonical sequence.

>P04424|ASL
     1  MASESGKLWG GRFVGAVDPI MEKFNASIAY DRHLWEVDVQ GSKAYSRGLE KAGLLTKAEM
    61  DQILHGLDKV AEEWAQGTFK LNSNDEDIHT ANERRLKELI GATAGKLHTG RSRNDQVVTD
   121  LRLWMRQTCS TLSGLLWELI RTMVDRAEAE RDVLFPGYTH LQRAQPIRWS HWILSHAVAL
   181  TRDSERLLEV RKRINVLPLG SGAIAGNPLG VDRELLRAEL NFGAITLNSM DATSERDFVA
   241  EFLFWASLCM THLSRMAEDL ILYCTKEFSF VQLSDAYSTG SSLMPQKKNP DSLELIRSKA
   301  GRVFGRCAGL LMTLKGLPST YNKDLQEDKE AVFEVSDTMS AVLQVATGVI STLQIHQENM
   361  GQALSPDMLA TDLAYYLVRK GMPFRQAHEA SGKAVFMAET KGVALNQLSL QELQTISPLF
   421  SGDVICVWDY GHSVEQYGAL GGTARSSVDW QIRQVRALLQ AQQA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ASL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
356 nTPM

Expression across tissuesHPA

Tissue

  • liver: 356 nTPM
  • kidney: 61 nTPM
  • duodenum: 57 nTPM
  • colon: 52 nTPM
  • small intestine: 44 nTPM
  • stomach: 43 nTPM

Single-cell type

  • hepatocytes: 344 nCPM
  • colonocytes: 240 nCPM
  • enterocytes: 239 nCPM
  • enteric transient amplifying cells: 132 nCPM
  • tuft cells: 127 nCPM
  • goblet cells: 107 nCPM

Immune cell

  • NK-cell: 74 nTPM
  • eosinophil: 51 nTPM
  • intermediate monocyte: 47 nTPM
  • myeloid DC: 46 nTPM
  • classical monocyte: 43 nTPM
  • non-classical monocyte: 36 nTPM

Brain region

  • pons: 14 nTPM
  • choroid plexus: 11 nTPM
  • hypothalamus: 10 nTPM
  • thalamus: 8.8 nTPM
  • medulla oblongata: 8.6 nTPM
  • midbrain: 8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ASL.

Disease | AllUniProt

Conditions ASL is implicated in, by any mechanism.

Disease | GeneticClinVar

239 pathogenic / likely-pathogenic of 964 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.94
gnomAD pLI
0
gnomAD missense Z
0.75
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ASL as an antibody target. Whether an autoantibody or antibody against ASL could matter depends on whether native ASL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ASL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ASL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ASL. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...